CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Large Increase in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 20,300 shares, a growth of 10.3% from the December 15th total of 18,400 shares. Based on an average daily trading volume, of 163,500 shares, the days-to-cover ratio is currently 0.1 days.

CERo Therapeutics Stock Up 9.2 %

Shares of CEROW traded up $0.00 during trading hours on Monday, reaching $0.02. 37,939 shares of the company traded hands, compared to its average volume of 290,885. The stock’s fifty day moving average is $0.01 and its 200 day moving average is $0.01. CERo Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.25.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.